Advanced search
Publication Cover
Renal Failure Volume 39, 2017 - Issue 1
Submit an article Journal homepage
1,384
Views
17
CrossRef citations to date
0
Altmetric
Laboratory Study

Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms

Xi QiaoDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; Correspondence[email protected]
View further author information
,
Lihua WangDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; View further author information
,
Yanhong WangDepartment of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, ChinaView further author information
,
Xiaole SuDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; View further author information
,
Yue QiDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; View further author information
,
Yun FanDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; View further author information
&
Zhiqiang PengDepartment of Nephrology, Second Hospital of Shanxi Medical University, Shanxi, China; ;Shanxi Kidney Disease Institute, Shanxi, China; View further author information
 show all
Pages 652-659 | Received 04 Apr 2017, Accepted 25 Jul 2017, Published online: 14 Aug 2017

References

  • Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63:789–797.
  • Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299–2306.
  • Park SA, Kim MJ, Park SY, et al. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling. Cell Mol Life Sci. 2015;72:2023–2039.
  • Roh J, Chang CL, Bhalla A, et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem. 2004;279:7264–7274.
  • Qiao X, Wang L, Wang Y, et al. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction. Nephrology (Carlton). 2015;20:820–831.
  • Barnes JL, Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 2011;79:944–956.
  • Jha JC, Gray SP, Barit D, et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol. 2014;25:1237–1254.
  • Geiszt M, Kopp JB, Varnai P, et al. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA. 2000;97:8010–8014.
  • Shiose A, Kuroda J, Tsuruya K, et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem. 2001;276:1417–1423.
  • Sedeek M, Callera G, Montezano A, et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2010;299:F1348–F1358.
  • Eid AA, Ford BM, Bhandary B, et al. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes. 2013;62:2935–2947.
  • Yoshimoto T, Gochou N, Fukai N, et al. Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res. 2005;28:165–172.
  • Qiao X, Li RS, Li H, et al. Intermedin protects against renal ischemia–reperfusion injury by inhibition of oxidative stress. Am J Physiol Renal Physiol. 2013;304:F112–F119.
  • Wang Y, Li R, Qiao X, et al. Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression. Nephrology (Carlton). 2013;18:623–632.
  • Ford BM, Eid AA, Gooz M, et al. ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice. Am J Physiol Renal Physiol. 2013;305:F323–F332.
  • Eid AA, Ford BM, Block K, et al. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem. 2010;285:37503–37512.
  • Holterman CE, Read NC, Kennedy CR. Nox and renal disease. Clin Sci. 2015;128:465–481.
  • Schramm A, Matusik P, Osmenda G, et al. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol. 2012;56:216–231.
  • Rubattu S, Mennuni S, Testa M, et al. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int J Mol Sci. 2013;14:23011–23032.
  • Gorin Y, Block K. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?. Free Radic Biol Med. 2013;61:130–142.
  • Sedeek M, Nasrallah R, Touyz RM, et al. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24:1512–1518.
  • Aslam M, Pfeil U, Gunduz D, et al. Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br J Pharmacol. 2012;165:208–222.
  • Li P, Sun HJ, Han Y, et al. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats. Peptides 2013;47:1–6.
  • Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21:37–46.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.